
ImmunoCellular Therapeutics
Immunocellular Therapeutics’ work in industry-leading, next-generation cancer vaccine immunotherapies.
Market cap
$8.5m
Enterprise value
$8m
Share price
$0.10 IMUC
Authorizing premium user...
Immunocellular Therapeutics’ work in industry-leading, next-generation cancer vaccine immunotherapies.